Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Linagliptin+Metformin is a fixed-dose combination API for type 2 diabetes, integrating DPP-4 inhibition with biguanide action. The formulation typically employs direct compression or wet granulation processes. Key parameters: Linagliptin (CAS 654670-91-8) and Metformin HCl (CAS 1115-70-4).